By Wendy Van Sickle
Columbus, Ohio, April 27 – UBS AG, London Branch priced $4.54 million contingent income auto-callable securities due April 25, 2019 linked to the common stock of Amgen Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 10.1% if Amgen stock closes at or above its downside threshold, 80% of their initial level, on the determination date for that quarter.
The notes will be called at par of $10 plus the contingent coupon if Amgen shares close above the initial level on any of the first 11 determination dates.
The payout at maturity will be par plus the final contingent coupon, unless Amgen shares finish below the 80% downside threshold, in which case investors will be fully exposed to any losses.
UBS Securities LLC is the agent, and Morgan Stanley Wealth Management is a distributor.
| Issuer: | UBS AG, London Branch
|
| Issue: | Contingent income autocallable securities
|
| Underlying stock: | Amgen, Inc. (Nasdaq: AMGN)
|
| Amount: | $4,544,520
|
| Maturity: | April 25, 2019
|
| Coupon: | 10.1% annualized, payable quarterly if shares close at or above downside threshold level on review date for that quarter
|
| Price: | Par of $10
|
| Payout at maturity: | If final share price is greater than or equal to trigger level, par plus contingent payment; otherwise, full exposure to the loss
|
| Call: | At par plus contingent payment if shares close at or above initial price on any of first 11 determination dates
|
| Initial share price: | $163.19
|
| Downside threshold: | $130.55, 80% of initial share price
|
| Pricing date: | April 22
|
| Settlement date: | April 27
|
| Agent: | UBS Financial Services Inc.
|
| Distributor: | Morgan Stanley Wealth Management
|
| Fees: | 2.5%
|
| Cusip: | 90275R414
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
